10-Q Filing

IMMIX BIOPHARMA, INC. CIK: 1873835 Q1 2025

Filing Information

Form Type	10-Q
Accession Number	`0001641172-25-009280`
Period End Date	20250331
Filing Date	20250508
Fiscal Year	2025
Fiscal Period	Q1
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 128 Income Statement 72 Cash Flow Statement 106 Stockholders Equity 52

Balance Sheet 128 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.68M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.68M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.92M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.92M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Tax receivable	`IncomeTaxReceivable`	$1.97M	USD	Point-in-time
Tax receivable	`IncomeTaxReceivable`	$1.97M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Tax receivable	`IncomeTaxReceivable`	-	USD	Point-in-time
Tax receivable	`IncomeTaxReceivable`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$541.51K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$541.51K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$858.14K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$858.14K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.20M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.20M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.78M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.78M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$20.42K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$20.42K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.92M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.92M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.61M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.61M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$20.42K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$20.42K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.54M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.54M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.85M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.85M	shares	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$968.44K	USD	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$968.44K	USD	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$989.47K	USD	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$989.47K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.74M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.74M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.12M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.12M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Total assets	`Assets`	$22.95M	USD	Point-in-time
Total assets	`Assets`	$22.95M	USD	Point-in-time
Total assets	`Assets`	$19.89M	USD	Point-in-time
Total assets	`Assets`	$19.89M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$9.24M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$9.24M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$8.62M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$8.62M	USD	Point-in-time
Operating lease liability - current	`OperatingLeaseLiabilityCurrent`	$65.22K	USD	Point-in-time
Operating lease liability - current	`OperatingLeaseLiabilityCurrent`	$65.22K	USD	Point-in-time
Operating lease liability - current	`OperatingLeaseLiabilityCurrent`	$67.82K	USD	Point-in-time
Operating lease liability - current	`OperatingLeaseLiabilityCurrent`	$67.82K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.69M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.69M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.31M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.31M	USD	Point-in-time
Operating lease liability long term	`OperatingLeaseLiabilityNoncurrent`	$991.13K	USD	Point-in-time
Operating lease liability long term	`OperatingLeaseLiabilityNoncurrent`	$991.13K	USD	Point-in-time
Operating lease liability long term	`OperatingLeaseLiabilityNoncurrent`	$1.01M	USD	Point-in-time
Operating lease liability long term	`OperatingLeaseLiabilityNoncurrent`	$1.01M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.70M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.70M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.30M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 27,924,704 shares issued and 27,852,341 shares outstanding at March 31, 2025 and 27,612,383 shares issued and 27,540,020 shares outstanding at December 31, 2024	`CommonStockValue`	$2.76K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 27,924,704 shares issued and 27,852,341 shares outstanding at March 31, 2025 and 27,612,383 shares issued and 27,540,020 shares outstanding at December 31, 2024	`CommonStockValue`	$2.76K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 27,924,704 shares issued and 27,852,341 shares outstanding at March 31, 2025 and 27,612,383 shares issued and 27,540,020 shares outstanding at December 31, 2024	`CommonStockValue`	$2.79K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 27,924,704 shares issued and 27,852,341 shares outstanding at March 31, 2025 and 27,612,383 shares issued and 27,540,020 shares outstanding at December 31, 2024	`CommonStockValue`	$2.79K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$88.37M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$88.37M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$89.24M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$89.24M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.06K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.06K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$15.46K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$15.46K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-75.02M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-75.02M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-79.57M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-79.57M	USD	Point-in-time
Treasury stock at cost, 72,363 shares as of March 31, 2025 and December 31, 2024	`TreasuryStockCommonValue`	$99.96K	USD	Point-in-time
Treasury stock at cost, 72,363 shares as of March 31, 2025 and December 31, 2024	`TreasuryStockCommonValue`	$99.96K	USD	Point-in-time
Treasury stock at cost, 72,363 shares as of March 31, 2025 and December 31, 2024	`TreasuryStockCommonValue`	$99.96K	USD	Point-in-time
Treasury stock at cost, 72,363 shares as of March 31, 2025 and December 31, 2024	`TreasuryStockCommonValue`	$99.96K	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.63M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.63M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.59M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.59M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.25M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.25M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$19.89M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$19.89M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$22.95M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$22.95M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.34M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.34M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.71M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.71M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.25M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.25M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.98M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.98M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.59M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.59M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.68M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.68M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.59M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.59M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.68M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.68M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$267.91K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$267.91K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$150.22K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$150.22K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$267.91K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$267.91K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$150.22K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$150.22K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.32M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.32M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.53M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.53M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$8.84K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$8.84K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$9.82K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$9.82K	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.54M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.54M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.33M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.33M	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-72.07K	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-72.07K	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to Immix Biopharma, Inc. common stockholders	`NetIncomeLoss`	$-5.26M	USD	1 Quarter
Net loss attributable to Immix Biopharma, Inc. common stockholders	`NetIncomeLoss`	$-5.26M	USD	1 Quarter
Net loss attributable to Immix Biopharma, Inc. common stockholders	`NetIncomeLoss`	$-4.54M	USD	1 Quarter
Net loss attributable to Immix Biopharma, Inc. common stockholders	`NetIncomeLoss`	$-4.54M	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.52K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.52K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-45.05K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-45.05K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$16.52K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$16.52K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-45.05K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-45.05K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-5.30M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-5.30M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.53M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.53M	USD	1 Quarter
Loss per common share - basic	`EarningsPerShareBasic`	$-0.15	USD	1 Quarter
Loss per common share - basic	`EarningsPerShareBasic`	$-0.15	USD	1 Quarter
Loss per common share - basic	`EarningsPerShareBasic`	$-0.22	USD	1 Quarter
Loss per common share - basic	`EarningsPerShareBasic`	$-0.22	USD	1 Quarter
Loss per common share - diluted	`EarningsPerShareDiluted`	$-0.22	USD	1 Quarter
Loss per common share - diluted	`EarningsPerShareDiluted`	$-0.22	USD	1 Quarter
Loss per common share - diluted	`EarningsPerShareDiluted`	$-0.15	USD	1 Quarter
Loss per common share - diluted	`EarningsPerShareDiluted`	$-0.15	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	29.70M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	29.70M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	23.44M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	23.44M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.70M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.70M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	23.44M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	23.44M	shares	1 Quarter

Cash Flow Statement 106 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-4.54M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.54M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.33M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.33M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$943.26K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$943.26K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$868.36K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$868.36K	USD	1 Quarter
Depreciation	`Depreciation`	$3.01K	USD	1 Quarter
Depreciation	`Depreciation`	$3.01K	USD	1 Quarter
Depreciation	`Depreciation`	$38.15K	USD	1 Quarter
Depreciation	`Depreciation`	$38.15K	USD	1 Quarter
Amortization of right of use asset	`FinanceLeaseRightOfUseAssetAmortization`	$21.03K	USD	1 Quarter
Amortization of right of use asset	`FinanceLeaseRightOfUseAssetAmortization`	$21.03K	USD	1 Quarter
Amortization of right of use asset	`FinanceLeaseRightOfUseAssetAmortization`	$20.84K	USD	1 Quarter
Amortization of right of use asset	`FinanceLeaseRightOfUseAssetAmortization`	$20.84K	USD	1 Quarter
Tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$-2.00M	USD	1 Quarter
Tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$-2.00M	USD	1 Quarter
Tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$911.54K	USD	1 Quarter
Tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$911.54K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$476.99K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$476.99K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$316.62K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$316.62K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherCurrentAssets`	$20.42K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherCurrentAssets`	$20.42K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherCurrentAssets`	-	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherCurrentAssets`	-	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.92M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.92M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$258.72K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$258.72K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-15.83K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-15.83K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$21.31K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$21.31K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.83M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.83M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.69M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.69M	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$301.91K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$301.91K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$67.71K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$67.71K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-301.91K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-301.91K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-67.71K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-67.71K	USD	1 Quarter
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$15.95M	USD	1 Quarter
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$15.95M	USD	1 Quarter
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$13.57M	USD	Point-in-time
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$13.57M	USD	Point-in-time
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromIssuanceInitialPublicOffering`	$2.49K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromIssuanceInitialPublicOffering`	$2.49K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$15.95M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$15.95M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Effect of foreign currency on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-10.37K	USD	1 Quarter
Effect of foreign currency on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-10.37K	USD	1 Quarter
Effect of foreign currency on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-8.00K	USD	1 Quarter
Effect of foreign currency on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-8.00K	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$11.81M	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$11.81M	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.76M	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.76M	USD	1 Quarter
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.51M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.51M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.32M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.32M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.68M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.68M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.92M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.92M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.51M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.51M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.32M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.32M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.68M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.68M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.92M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.92M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$8.84K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$8.84K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$9.82K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$9.82K	USD	1 Quarter
Establishment of right of use asset and liabilities	`RightOfUseAssetAndLiabilities`	-	USD	1 Quarter
Establishment of right of use asset and liabilities	`RightOfUseAssetAndLiabilities`	-	USD	1 Quarter
Establishment of right of use asset and liabilities	`RightOfUseAssetAndLiabilities`	$1.07M	USD	1 Quarter
Establishment of right of use asset and liabilities	`RightOfUseAssetAndLiabilities`	$1.07M	USD	1 Quarter
Purchase of property and equipment included in accounts payable and accrued expenses	`PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities`	$11.75K	USD	1 Quarter
Purchase of property and equipment included in accounts payable and accrued expenses	`PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities`	$11.75K	USD	1 Quarter
Purchase of property and equipment included in accounts payable and accrued expenses	`PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities`	$354.23K	USD	1 Quarter
Purchase of property and equipment included in accounts payable and accrued expenses	`PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities`	$354.23K	USD	1 Quarter
Deferred offering costs charged against proceeds from sale of common stock	`DeferredOfferingCostsChargedAgainstProceedsFromSaleOfCommonStock`	$87.23K	USD	1 Quarter
Deferred offering costs charged against proceeds from sale of common stock	`DeferredOfferingCostsChargedAgainstProceedsFromSaleOfCommonStock`	$87.23K	USD	1 Quarter
Deferred offering costs charged against proceeds from sale of common stock	`DeferredOfferingCostsChargedAgainstProceedsFromSaleOfCommonStock`	-	USD	1 Quarter
Deferred offering costs charged against proceeds from sale of common stock	`DeferredOfferingCostsChargedAgainstProceedsFromSaleOfCommonStock`	-	USD	1 Quarter
Shares issues for vested restricted stock awards	`SharesIssuesForVestedRestrictedStockAwards`	$16.00	USD	1 Quarter
Shares issues for vested restricted stock awards	`SharesIssuesForVestedRestrictedStockAwards`	$16.00	USD	1 Quarter
Shares issues for vested restricted stock awards	`SharesIssuesForVestedRestrictedStockAwards`	-	USD	1 Quarter
Shares issues for vested restricted stock awards	`SharesIssuesForVestedRestrictedStockAwards`	-	USD	1 Quarter

Stockholders Equity 52 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.63M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.63M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.20M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.20M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.59M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.59M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.25M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.25M	USD	Point-in-time
Treasury shares, balance	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Treasury shares, balance	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Treasury shares, balance	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Treasury shares, balance	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Shares issued for vested restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Shares issued for vested restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Shares issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$266.25K	USD	1 Quarter
Shares issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$266.25K	USD	1 Quarter
Shares issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$327.38K	USD	1 Quarter
Shares issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$327.38K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$602.11K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$602.11K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$615.89K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$615.89K	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.54M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.54M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.33M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.33M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-45.05K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-45.05K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$16.52K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$16.52K	USD	1 Quarter
Shares issued under ATM facility for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueUnderAtmFacilitiesForCashProceedsNetOfOfferingCosts`	$338.50K	USD	1 Quarter
Shares issued under ATM facility for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueUnderAtmFacilitiesForCashProceedsNetOfOfferingCosts`	$338.50K	USD	1 Quarter
Shares issued under public offering for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$15.52M	USD	1 Quarter
Shares issued under public offering for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$15.52M	USD	1 Quarter
Shares issued for exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.49K	USD	1 Quarter
Shares issued for exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.49K	USD	1 Quarter
Shares issued for exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-	shares	1 Quarter
Shares issued for exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-	shares	1 Quarter
Non-controlling interests in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	1 Quarter
Non-controlling interests in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.63M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.63M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.20M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.20M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.59M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.59M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.25M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.25M	USD	Point-in-time
Treasury shares, balance	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Treasury shares, balance	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Treasury shares, balance	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Treasury shares, balance	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.